| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 03/03/2005 | WO2005019164A2 Preparation of phenethanolamine derivatives |
| 03/03/2005 | WO2005018529A2 Phenoxiacetic acid derivatives |
| 03/03/2005 | WO2005000309A3 Chemical compounds |
| 03/03/2005 | US20050049310 Aryl and heteroaryl compounds, compositions and methods of use |
| 03/03/2005 | CA2535714A1 Phenoxyacetic acid derivatives |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1587252A Multiple photon absorptive phenyl fluorene derivative and its preparing method |
| 03/01/2005 | US6860926 Diperfluoroalkyl- ester or sulfonamide ester derivatives |
| 02/24/2005 | WO2005016915A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 02/24/2005 | WO2005016870A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 02/24/2005 | WO2005016864A1 Conjugated nitro alkene anticancer agents based on isoprenoid metabolism |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016277A2 Arylsulfonamidobenzylic compounds |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043364 Novel pyrrole-based HMG-CoA reductase inhibitors |
| 02/24/2005 | US20050043358 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043244 Sulfur compounds such as 4-(N-(1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)hydrazin-2-yl-carbonayl)-N -methyaminomethyl)phenyl oxycarbonyl-glutamic acid, used as sulfonyl hydrazine prodrugs(SHPs) having antitumor activity in mammals |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534850A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/24/2005 | CA2533638A1 Arylsulfonamidobenzylic compounds |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585744A Process for the preparation of benazepril |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/22/2005 | US6858691 Exhibit extensive delocalization of the negative charge and good activity in polymerization or in copolymerization and allow the preparation of macromolecules possessing dissociated and stable ionic functional groups |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858565 Color developers; recording images |
| 02/22/2005 | US6858434 Using thin layer chromatography for rapid preparation and screening of lead structures for drug candidates; rational drug design |
| 02/17/2005 | WO2005014539A2 Pyrrole-based hmg-coa reductase inhibitors |
| 02/17/2005 | WO2005014534A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/17/2005 | WO2005014533A2 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/17/2005 | WO2005014532A1 Aryl and heteroaryl compounds, compositions and methods of use |
| 02/17/2005 | WO2005013995A1 4-substituted 7-alkoxy-2-aminosulfonyl-1,2-dihydro-phtalazin derivatives as phosphodiesterase 4 inhibitors for the treatment of allergies and inflammations |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004113278A3 Acylsulfamide inhibitors of factor viia |
| 02/17/2005 | WO2004016578A8 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | US20050038259 Elastase release inhibitors; such as 19-(1H-tetrazol-5-yl)nonadec-6-en-5-ol |
| 02/17/2005 | US20050038248 Chemotherapeutic agents |
| 02/17/2005 | US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion |
| 02/17/2005 | US20050038117 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity |
| 02/17/2005 | US20050038100 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders; hyperphagia |
| 02/17/2005 | US20050038026 amidation of 2-[Carbamoylmethyl-(3-nitro-benzenesulfonyl)-amino]acetamide from 2-(3-Nitro-benzenesulfonylamino)acetamide with N,N-Dimethylformamide in the presence of ClCH2CONH2 and a base; by-product inhibition, high purity |
| 02/17/2005 | US20050038019 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534494A1 Pyrrole-based hmg-coa reductase inhibitors |
| 02/17/2005 | CA2531796A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/16/2005 | EP1506167A1 Hydroxy tetrahydro-naphthalenylurea derivatives |
| 02/16/2005 | EP1506158A2 Diamino-functional chalcones |
| 02/16/2005 | EP1506157A2 Amino-functional chalcones |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1244617B1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855695 Water-soluble SHPs as novel alkylating agents |
| 02/15/2005 | US6855657 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions |
| 02/10/2005 | WO2005012239A1 Ionically dissociative functional molecules, processes for production thereof, ionic conductors, and electrochemical equipment |
| 02/10/2005 | WO2005012238A1 Process for the preparation of cpla2 inhibitors |
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
| 02/10/2005 | US20050033047 such as 2-dimethylaminocarbonyl-5-nitro-n-4-[(4,6-dimethoxypyrimidin-2-yl)aminocarbonyl]benzene-sulfonamide via halogenation, ammonolysis, reduction, and reaction with carbamates; herbicides; plant growth regulators |
| 02/10/2005 | US20050032889 (2R,3S)-N-(3-Amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-aminobenzenesulfonamide, intermediate to HIV protease inhibitors; Industrially improved catalytic reduction of a 4-nitrobenzenesulfonamide crystal; crystallization using good polar solvent and water nonsolvent; efficient drying with heptane |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/09/2005 | EP1505054A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative |
| 02/09/2005 | EP1504760A1 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy |
| 02/09/2005 | EP1503981A2 Substituted tetracycline compounds |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/09/2005 | CN1578763A Selective herbicides based on substituted arylsulfonylaminocarbonyl triazolinones and safeners |
| 02/09/2005 | CN1578762A Process for resolution of tamsulosin and compounds, compositons, and processes associated therewith |
| 02/09/2005 | CN1578761A Process for resolution of tamsulosin |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188388C Aminobenzophenones as inhibitors of interleukin and TNF |
| 02/08/2005 | US6853472 Electrolytes for electrooptic devices comprising ionic liquids |
| 02/08/2005 | US6852887 Dehalogenation, amination; a viricides treating Human immunodeficiency virus (HIV), Acquired immunodeficiency syndrome (AIDS) |
| 02/08/2005 | US6852761 Inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular |
| 02/08/2005 | US6852747 Resorcinol derivatives |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2004024089A3 Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing |
| 02/03/2005 | WO2004001877A3 Electrolytes for electrooptic devices comprising ionic liquids |
| 02/03/2005 | US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer |
| 02/03/2005 | US20050026844 Inhibitors for the soluble epoxide hydrolase |
| 02/03/2005 | US20050026812 Conjugated nitro alkene anticancer agents based on isoprenoid metabolism |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/02/2005 | EP1501793A1 Tamsulosin derivative |
| 02/02/2005 | EP1330233B1 Method of treating stroke |